Skip to main content
Iranian Biomedical Journal logoLink to Iranian Biomedical Journal
. 2017 Sep;21(5):285–293. doi: 10.18869/acadpub.ibj.21.5.285

Therapeutic effects of Iranian herbal extracts against Trichomonas vaginalis

Zohreh Fakhrieh Kashan 1, Mahdi Delavari 2,*, Mohsen Arbabi 2, Hossein Hooshyar 2
PMCID: PMC5548960  PMID: 28755655

Abstract

Trichomonas vaginalis is a flagellated parasite affecting about 276 million people annually worldwide. Tricomoniasis is associated with different complications in pregnant women and infants. 5’-nitroimidazole derivatives (metronidazole, ornidazole, and tinidazole) are FDA approved drugs recommended for trichomoniasis treatment. Treatment with metronidazole 5’-nitroimidazole derivatives is associated with many side effects, and drug resistance to metronidazole has been reported in some cases. Recently, many attempts have been made to evaluate the effects of plants on causative agents of vaginal infections. In our research, the national and international databases were searched and the effects of various herbal extracts on T. vaginalis in Iran were reviewed from 2006 to 2016. In articles investigated, some plants had favorable antitrichomonal effects and needed to be further investigated. All the plant extracts have only been evaluated in vitro. Surveys of different articles in this review show that the active ingredients present in different parts of plants, including aerial parts, leaves, flowers, stems, and root can be suitable sources for introducing and developing new antitrichomonal compounds

Keywords: Trichomonas vaginalis, Medicinal plants, Iran, Herbal, Extract

INTRODUCTION

Trichomonas vaginalis is a protozoan parasite and the causative agent of infection in human vagina, prostate gland, and urethra[1-3]. T. vaginalis is a parasite of the Trichomonadidae family and genus of Trichomonas. Morphologically, this parasite is pyriform and occasionally amoeboid form[3-6]. Prevalence of trichomoniasis is estimated about 276 million new cases annually worldwide and associated with different complications such as preterm birth, high mortality in infant, and low birth weight[7-9]. About 85% of infected women and 77% of infected men with this parasite are asymptomatic. In men, trichomoniasis can be associated with urethral discharge and dysuria. In general, among women, the common sites of infection are vagina, urethra, and endocervix, and clinical features include vaginal discharge (which is often diffuse, malodorous, and yellow-green), dysuria, itching, pruritis, vulvar irritation, and abdominal pain. Other complications could be infection of the adnexal, endometrium, and Skene’s and Bartholin’s glands. Trichomoniasis also may cause the increased risks of other sexually transmitted diseases; infection is associated with 1.5–2.7 times greater risks of HIV acquisition and transmission[10-13]. Trichomoniasis in women is more common at the age of 16-53. Infection is usually transmitted by sexual contact and restricted to the genital tract. Wet mount examination is the most common method of diagnosis, but T. vaginalis infection can also be diagnosed by clinical signs, cultures (TYM, TYI-S-33, dorset, and horse serum), and molecular approaches such as polymerase chain reaction, which is the most sensitive and specific method for the detection of T. vaginalis[14-16]. The appropriate treatment for trichomoniasis includes the 5’-nitroimidazole derivatives of which metronidazole and tinidazole are the only efficient FDA approved drugs. Recently, some other drugs have been introduced for the treatment of this disease (Table 1)[17-29]. Besides, simultaneous treatment of both sexual partners (female and male) is recommended[17-20]. Treatment efficiency depends on the influence of host factors. Nitroimidazole may also be required for the effective treatment of HIV-infected women who are infected with T. vaginalis. Drug resistance to metronidazole has been reported in some cases[30,31]. In recent years, many attempts have been made for the evaluation of the effects of plants on different microorganisms that cause vaginal infection on T. vaginalis in vaginal infection. Nowadays, many studies have been performed in replacing medicinal plants with synthetic drugs[32-36].

Table 1.

Chemotherapeutic agents against trichomoniasis

Drug name Medial use Ref.
Metronidazole Anti-protozoan (giardiasis, trichomoniasis, and amebiasis) [17-20]
Tinidazole Anti-protozoan (amebiasis, giardiasis, and trichomonasis) [21,22]
Secnidazole Anti-protozoan (trichomonasis and dientamoebiasis) [21,29]
Ornidazole Anti-protozoan (trichomoniasis) [23]
Nimorazole Anti-protozoan (trichomoniasis and head and neck cancer) [24]
Nitrothiazole Anti-protozoan (giardiasis, trichomoniasis, and amebiasis) [25]
Nitazoxanide Anti-protozoan (cryptosporidiosis, giardiasis, hymenolepiasis, ascariasis, and resistant Trichomoniasis) [26,25]
Hamycin Anti-protozoan (trichomoniasis) [27]
Paramomycin Cutaneous leishmaniasis, visceral leishmaniasis, and anti-recurrent T. vaginalis [28]
Sodium nitrite Anti-microbial and anti-T. vaginalis resistance to metronidazole (used in traditional medicine) [29]
Nitrofuran Antimicrobials and anti-T. vaginalis [29]
Furazolidone Antibacterial and anti-T. vaginalis [29]

Ref., references

Search of electronic databases and journals was performed to find the related data reporting the in vitro effects of various plant extracts on T. vaginalis in Iran. The international databases, including PubMed, Scirus, ISI Web of Science, Scopus, EMBASE, Science Direct, and Google Scholar, as well as national databases covering Iran Medex, IranDoc, Magiran, and Scientific Information Database (ISC) were searched. These searches limited to articles published between the years 2006 and 2016. The keywords used for the literature search for this review were “Trichomonas vaginalis”, “medicinal plants”, “herbal drug”, “plant extract”, “anti-trichomonas activity”, “in vitro”, and “Iran”.

Chemical drugs for treatment of trichomoniasis

Metronidazole

Metronidazole is a member of the nitroimidazole family and prevents genetic material synthesis by disrupting the DNA of microrganism cells. Metronidazole is highly active against anaerobic bacteria and anaerobic parasites including T. vaginalis[30,37]. The pharmacological properties of this drug are suitable, and it is accessible as oral, intravenous, vaginal, and topical forms. After oral administration, it is well absorbed and reached the highest level within 1 to 2 hours after ingestion[30,37,38]. This drug is effective against many anaerobic bacteria and parasites. Urinary tract is the prominent way of metronidazole excretion. Anaerobic infections, such as abdominal infections, genital tract infections, septicemia, endocardial infection, bone infections, brain and spinal cord infections, pulmonary infections, cutaneous infections. Before some surgeries, metronidazole is used to prevent secondary infections[30,37,38].

Side effects and the problem of metronidazole resistance

Side effects in systemic metronidazole therapy (in less than 1% of patients) include vomiting, diarrhea, abdominal cramps, headache, drowsiness and fever. Intravenous administration is typically associated with thrombophlebitis. Infrequent side effects consists mouth ulcers, headache, glossitis, dizziness, inflammation of the mouth and lips and dark-colored urine[17-29,39]. Irregular and long-term use of the metronidazole has led to drug resistance, which is the most important reason for the treatment failure[37]. If there is suspicion of metronidazole resistance, metronidazole susceptibility assay is required as it can help to determine the course of subsequent treatment[29,40]. The increase in the prevalence of metronidazole-resistant strains shows a need for development of non-nitroimidazole drugs to combat resistant trichomoniasis. Recently, some studies have been conducted to introduce new drugs against trichomoniasis. The use of herbal medicines has been considered due to fewer side effects. While the synthetic drugs are obtained from non-renewable sources as petrochemicals materials, medicinal plants, are renewable in nature[30-36,41].

Tinidazole

Tinidazole is antiparasitic drug from the 5-nitro-imidazole family. This drug is commonly used for treating T. vaginalis in America. Compared to metronidazole, tinidazole has longer half-life, higher tissue distribution, and fewer side effects. However, its mechanism of action is similar to metronidazole, and the occurrence of cross-resistance is possible. Studies have shown an incomplete cross-resistance to tinidazole in metronidazole-resistant isolates that can possibly be treated by tinidazole, but the similarity of metabolic pathways in metronidazole and tinidazole causes the rapid spread of resistance to tinidazole. Also, its cost is more than metronidazole; therefore, it cannot be used commonly[22,42].

Literature review of herbal medicine for treatment of trichomoniasis

Active ingredients of plant extract against T. vaginalis are mentioned in Table 2.

Table 2.

Active ingredients of plant extracts against T. vaginalis in Iran (2006-2016)

Botanical name Active ingredients Part used
Artemisia aucheri Boiss. Artemisinin[43,51] Leaves
Zataria multifora Boiss. Thymol[44-47,51] Leaves
Myrtus communis Cineol, tannins, and flavonoids[48-51] Leaves
Allium sativum (garlic) Organosulfur compound, Allicin, Diallyl disulphide, S-Allyl cysteine, and Diallyl trisulfide[52,53,56] Whole plant
Ferula assa-foetida Monoterpenoids[54-56] Whole plant
Lavandula angyustifolia Linalool alcohol, Cineol, Camohor, Sterzoaldehyde ketone, and lavandulol[57-59] Leaves and flowers
Eucalyptus camaldulensis Terpenoid and phenolic compound[60,61] Leaves
Stachys sylvatica α-Pinene, β-Pinene, germacrene-D, and flavonoids[62,63] Aerial parts
Achillea millefolium Flavonoids[64,67] whole plant and leaves
Artemisia absinthium Monoterpene (thujone), absinthen, azulenes, phenolic compounds, Flavonoids[66,67] Leaves
Juglans regia Tannin and naphthoquinones[65,67] Leaves and twigs
Tanacetum Parthenium Tancin, lactones, and terpenes[68,69] Leaves
Taxus baccata Alkaloids (taxines A and B)[70,71] Leaves
Viola odorata Phenolic, terpenoid, and alkaloid compounds[72,73] Leaves, flowers, and stems
Pelarqonium roseum Geranium, citronellol, mannitol, and ethyl alcohol[74,75] Leaves, flowers, and roots
Verbascum thapsus Saponins, glycosides, glycosoaminoglycans, phenyl ethanol, and verbascose[76,77] Leaves, flowers, and stems
Allium Cepa Organosulfur compounds, Allyl sulfides, flavonoids, and flavenols[78,81] Whole plant
Oliveria Decumbens Vent Tymol, threpenin, and carvacrol[79] Aerial parts
Muscari neglectum Flavonoid, alkaloid, terpenoid, and steroid[80,81] Flowers

Artemisia aucheri Boiss, Zataria multifora Boiss, and Myrtus communis

These plants are native in Iran and are used in traditional medicine as antiparasitic drugs. Artemisia aucheri Boiss contains artemisinin, which has antiparasitic properties[43], and Zataria multifora Boiss contains the high amount of thymol, which has anti-inflammatory, antiseptic and antibacterial effects[44-47]. Myrtus communis is composed of cineol, tannins and flavonoids, which have antiseptic, antioxidant, antibacterial, antiviral and antifungal activities[48-50]. Ziaiye et al.[51] surveyed the effect of alcoholic extract of these three plants on T. vaginalis in vitro. Their results showed that these extracts have different chemical compositions and special effects that inhibit the growth of T. vaginalis. Also, all of them had maximum effect in 0.1% w/v and 4 hours after culture so that after this time no parasites were found alive.

Garlic and Ferula assa-foetida

Allium sativum, is the scientific name of garlic, belongs to onion genus. Garlic is native to Central Asia and has been used over than 7000 years. Garlic is used as anticoagulant, anticommon cold, anti cancer and antiparasite[52,53]. Ferula assa-foetida is native to the deserts of Iran and mountains of Afghanistan and is commonly cultivated in nearby India. This plant grows in different provinces of Iran such as Khorasan, Sistan and Baluchestan, Kerman, and Fars. Ferula assa-foetida is used as a digestion aid, antimicrobial, abortifacient, antidote for opium, remedy for asthma and bronchitis, and fighting influenza[54,55]. Sarkari et al.[56] studied the effect of garlic and Ferula assa-foetida extract on the growth and proliferation of T. vaginalis. Based on the results of this study, 90% of the parasites were killed one hour after adding Ferula assa-foetida extract at the concentration of 2 mg/ml, but only 5% of the parasites survived after 2 hours by adding garlic extract at concentration of 0.1 mg/ml.

Lavandula angyustifolia

Lavandula belongs to family Lamiceae and genus Lavanduleae. This plant has traditional application as a sedative as well as an antispasmodic, antiparasitic, antibacterial, antioxidant, anticancer, antivirus, antidepressants and anti-inflammatory remedy[57,58]. Investigation of antitrichomonal activity of Lavandula angyustifolia essential oil in vitro was conducted by Ezatpur et al.[59]. They showed that all concentrations of lavender essential oil have good antitrichomonal effect and reduce the number of parasites; all the parasites were killed 90 minutes after exposure to 0.1% Lavandula angyustifolia essential oil.

Eucalyptus camaldulensis

Various biological effects of eucalyptus, including antibacterial, antihyperglycemic, and antioxidant activities have been reported, and it seems that the essential oils of Eucalyptus, containing terpenoid and phenolic compounds, play a major role in its biological activities[60]. Effects of various concentration of Eucalyptus camaldulensis extracts on T. vaginalis parasite in culture medium have been surveyed by Hassani et al.[61]. The obtained results indicated that E. camaldulensis extract had 80% growth inhibition in a concentration of 12.5 mg/ml after 24 h. Alcoholic extract in a concentration of 25 mg/ml showed 100% growth inhibition after 24 h, and ethyl acetate extract had 100% growth inhibition with the minimum concentration of 12.5 mg/ml 24 h after culture. Eventually, water extract in the concentration of 50 mg/ml indicated 80% and 100% growth inhibition after 48 and 72 h, respectively[61].

Stachys sylvatica

Stachys is one of the largest genera in the Lamiaceae plant family. It is a genus of about 300 species and a subfamily of Lamioideae. The distribution of the genus covers Europe, Asia, Africa, Australasia, and North America. This plant grows in different regions of Iran’s provinces such as Isfahan, Chaharmahal and Bakhtiari, and Lorestan. In traditional medicine, this herb is considered as anti-pain, anti-neuralgia, antioxidant, antipyretic, and appetizer[62]. Sereshti et al.[63] investigated the effect of aqueous and alcoholic extracts of the plant Stachys sylvatica on T. vaginalis in vitro. Their results indicated that aqueous and alcoholic extracts of the plant after 72 hours in medium culture TYI-S-33 had no effect on T. vaginalis, and metronidazole was more effective than this extract[63].

Achillea millefolium, Juglans regia, and Artemisia absinthium

Achillea millefolium is a flowering plant in the family Asteraceae. It is native to the temperate regions of the Northern Hemisphere in Asia, Europe, and North America. This plant has anti-inflammatory, antispasmodic and antioxidant activities[64]. Juglans regia belongs to the Juglandaceae family and Juglans genus and has tannin and naphthoquinones with potent bactericidal effects. The extract of this tree is used to treat headaches, colds, skin diseases, as well as fungal, bacterial and viral infections[65]. Artemisia absinthium belongs to the Asteraceae family and genus of Artemisia. This plant has medicinal properties, including insecticide and appetizer, as well as bactericidal, anti-inflammatory and antiparasitic effects[66]. The leaves extracts of Achillea millefolium, Artemisia absinthium, and Juglans regia on T. vaginalis was studied by Khalili et al.[67] in vitro. All three plant extracts represented anti-trichomoniasis activity after 24 hour and parasites immobility increased. However, six hours after cultivation with Achillea millefolium, Artemisia absinthium, and Juglans regia extracts at the concentrations of 800, 400, and 800 mg/ml, respectively, all parasites were died[67].

Tanacetum parthenium

Tanacetum parthenium (local name: fever few) belongs to Asteraceae family and is a native plant in Iran[68,69]. Tanacetum parthenium, as a traditional medicinal herb, is commonly used to prevent migraine headaches and has been used as a herbal treatment to reduce fever, arthritis, and digestive problems[68,69]. Its main compound is tannin, and others compounds include lactones (parthenolide and canine) and terpenes[68,69]. Study of the effect of hydro-alcoholic extract of Tanacetum Parthenium on T. vaginalis was conducted by Arefkhah et al.[69]. Alcoholic extract of this plant with concentrations of 4, 5, 8, and 10 mg/ml showed the same lethal effect on the parasite as compared to metronidazole, but concentrations of 1 and 1.25 indicated no effect[69].

Taxus baccata

Taxus baccata is a conifer native to Western, Central and Southern Europe, as well as Northwestern Africa, Northern Iran, and Southwestern Asia[70,71]. This traditional medicine plant has antibacterial, antifungal, anti-inflammatory and antitumoral activities and is used for treating malaria, rheumatism, bronchitis, and asthma[70,71]. In 2013, Zarea et al.[71] investigated the effects of Taxus baccata leaves fractions on T. vaginalis growth in culture medium. The component of 60% of crude extract at concentrations of 200, 300, 400, and 500 μg/ml indicated higher anti-T. vaginalis effects than 90% (P<0.05). Concentration of 200 μg/ml of the extract of 60% caused 100% inhibition, but the component of 90% indicated 60% growth inhibition[71].

Viola odorata

Viola odorata is a species of the genus Viola that is native to Europe and Asia and has been introduced to North America and Australia. In herbal medicine, V. odorata has been used for treating a variety of respiratory ailments, insomnia, and skin disorders[72,73]. Its compounds include phenolics, violin, and glycosides. In the leaves of this plant, analgesic components are salicylic acid glycosides[72,73]. The effects of different extracts of Viola odorata on T. vaginalis in culture medium has investigated by Salehi et al.[73]. The crude extract of leave (4 mg/ml), flower (4 mg/ml), and root (2 mg/ml) of Viola odorata showed 100% growth inhibition after 24 hours[73].

Pelarqonium roseum

Pelarqonium roseum belongs to the Geraniaceae family and Pelargonium genus. The major compounds of this plant are geranium, citronellol, mannitol, and ethyl alcohol[74,75]. It is used in traditional medicine as analgesic, anti-dysentery, and disinfectants as well as an anti-inflammatory, a hemostatic, and an antiseptic drug[74,75]. Fakhrie-Kashan et al.[75] studied the effects of aqueous and alcoholic extracts of Pelarqonium roseum on the growth of T. vaginalis in vitro. IC50s (inhibitory concentration, 50%) of aqueous and alcoholic extracts of Pelarqonium roseum on the growth of T. vaginalis after 24 h were 54.67 and 27.63 μg/ml, respectively[75].

Verbascum thapsus

Verbascum thapsus is a member of scorphulariaceae family. This biennial plant grows in a wide range of areas and can be two meters or more in height[76,77]. Verbascum thapsus contains bioactive substances such as saponins, glycosides, glycosoaminoglycans, phenyl ethanol, and verbascose[76,77] and also chemical components that reduce cyclooxygenase activity. These components have anti-inflammatory activity and germicide and skin restore effects[76,77]. Verbascum thapsus has also been used to treat genital and urinary tract infections and diarrhea[76,77]. Induction of apoptosis in T. vaginalis due to the extract of this plant have been reported by Kashan et al.[77]. IC50s (inhibitory concentration, 50%) of ethanolic extract of Verbascum thapsus and metronidazole after 24 h were 39.17 and 0.0326 μg/ml, respectively. Results of this study indicated that the percentage of apoptosis after treatment of parasites with various concentrations of Verbascum thapsus extract (25, 50,100, 200, and 400 μg/ml) were 20.7, 37.04, 47.5, 62.72, and 86.35 respectively[77].

Allium cepa, Oliveria decumbens Vent, and Muscari neglectum

The onion is a vegetable and the most widely cultivated species of the genus Allium. This plant grows in most parts of the world and Iran flora. It is used in traditional medicine for treatment of diseases of kidney, bladder, and prostate[78]. Oliveria decumbens Vent belongs to Umbeliferae family and grows in Southern Iran. It is bactericide and contains tymol, threpenin, and carvacrol[79]. Museari negleetum is native to the Mediterranean region[80,81]. In 2015, Fakhrieh-Kashan et al.[81] investigated the in vitro therapeutic effect of alcoholic extracts Allium cepa, Oliveria decumbens Vent, and Muscari neglectum against T. vaginalis. In this study, IC50s of Allium cepa, Oliveria decumbens Vent, and Muscari neglectum ethanol extracts after 24 h were 572.3, 101.8, and 329.4 μg/ml, respectively[81].

In conclusion, trichomoniasis is considered as one of the most common sexually transmitted diseases in humans[1,2]. Increasing resistance to drugs such as metronidazole leads to a serious problem; thus, new effective tactics are needed to treat this infection. The current medications and the first-line drugs for treatment of trichomoniasis are metronidazole and tinidazole; both are 5-nitroimidazole drugs approved by the US FDA. Besides, using metronidazole is limited because of its high toxicity, high doses, and development of drug resistance[30,37-39]. In order to improve the treatment of T. vaginalis infection, natural products could be a source of new drugs with low toxicity and high activity. Recently, many efforts have been made for the evaluation of the effects of plants on the pathogenic microorganisms that can lead to vaginal infection. Due to the diversity of Iranian medicinal plants, several studies have carried out on the T. vaginalis using these herbs. Unfortunately, previous studies have not used an identical procedure; therefore, we cannot exactly explain which plant extracts are more effective on the parasite. However, we can draw the conclusion that all plants with the largest effect on the parasites contain the following active compounds: cineol, tannins, flavonoid, terpenoid, phenolic ones, Artemisia, lactones, glycosides, geranium, citronium, mannitol, saponins, glycosoaminoglycans, verbascose, phenyl ethanol, tymol, threpenin, carvacrol, zingerone, paradol, gingerols, shogaols, inulin, polyacetylene, arctic aside. Until now, no herbal extract has been introduced as an approved drug for the treatment of trichomoniasis. More accurate and comprehensive studies are needed to achieve the desired results in the use of plants in trichomoniasis treatment.

Footnotes

CONFLICT OF INTEREST. None declared

REFERENCES

  • 1.Harp DF, Chowdhury I. Trichomoniasis:evaluation to execution. European journal of obstetrics and gynecology and reproductive biology. 2011;157(1):3–9. doi: 10.1016/j.ejogrb.2011.02.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Sutton M, Sternberg M, Koumans EH, McQuillan G, Berman S, Markowitz L. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States 2001-2004. Clinical infectious diseases. 2007;45(10):1319–1326. doi: 10.1086/522532. [DOI] [PubMed] [Google Scholar]
  • 3.Tobin W. Alfred Donnéand Léon Foucault:the first applications of electricity and photography to medical illustration. Journal of visual communication in medicine. 2006;29(1):6–13. doi: 10.1080/01405110600575993. [DOI] [PubMed] [Google Scholar]
  • 4.Nijhawan AE, Chapin KC, Salloway R, Andrea S. Prevalence and predictors of trichomonas infection in newly incarcerated Women. Sexually transmitted diseases. 2012;39(12):973–978. doi: 10.1097/OLQ.0b013e31826e8847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Mao M, Liu HL. Genetic diversity of Trichomonas vaginalis clinical isolates from Henan province in central China. Pathogens and global health. 2015;109(5):242–246. doi: 10.1179/2047773215Y.0000000020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Dirkx M, Boyer MP, Pradhan P, Brittingham A, Wilson WA. Expression and characterization of a β-fructofuranosidase from the parasitic protist Trichomonas. BMC biochemistry. 2014;15(12) doi: 10.1186/1471-2091-15-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.World Health Organization. Dept. of Reproductive Health and Research. REterieved from: http://www.who.int/reproductivehealth/about_us/en/
  • 8.Sharafi SM, Yousefi M, Yousefi HA, Asghari G, Darani HY. In vitro effects of various plants extracts on the growth of Trichomonas vaginalis. Infectious disorders drug targets. 2013;13(5):322–327. doi: 10.2174/1871526514666140321111329. [DOI] [PubMed] [Google Scholar]
  • 9.Sariego I, Monzote L, Rojas L. Setting a colorimetric assay with MTT for assessment of trichomonicidal activity. Current clinical pharmacology. 2014;9(3):283–287. doi: 10.2174/157488470903140806120218. [DOI] [PubMed] [Google Scholar]
  • 10.Sutton M, Sternberg M, Koumans EH, McQuillan G, Berman S, Markowitz L. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States 2001–2004. Clinical infectious diseases. 2007;45(10):1319–1326. doi: 10.1086/522532. [DOI] [PubMed] [Google Scholar]
  • 11.Sena AC, Miller WC, Hobbs MM, Schwebke JR, Leone PA, Swygard H, Atashili J, Cohen MS. Trichomonas vaginalis infection in male sexual partners:implications for diagnosis, treatment, and prevention. Clinical infectious diseases. 2007;44(1):13–22. doi: 10.1086/511144. [DOI] [PubMed] [Google Scholar]
  • 12.Manshoori A, Mirzaei S, Valadkhani Z, Kazemi Arababadi M, Rezaeian M, Zainodini N, Bahramabadi R, Zare-Bidaki M. A diagnostic and symptomatological study on trichomoniasis in symptomatic pregnant women in Rafsanjan, South Central Iran in 2012-13. Iranian journal of parasitology. 2015;10(3):490–497. [PMC free article] [PubMed] [Google Scholar]
  • 13.Secor WE, Meites E, Starr MC, Workowski KA. Neglected parasitic infections in the United States:trichomoniasis. American journal of tropical medicine and hygiene. 2014;90(5):800–804. doi: 10.4269/ajtmh.13-0723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Camila BM, Mariana dos SM, Tiana TASCA. Comparsion of permanent staining methods for the laboratory diagnosis of trichomoniasis. Revista do instituto de medicina tropical de são Paulo. 2016;58(5) doi: 10.1590/S1678-994620160005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Mahmoud A, Sherif NA, Abdella R, El-Genedy AR, El Kateb AY, Askalani AN. Prevalence of Trichomonas vaginalis infection among Egyptian women using culture and Latex agglutination:cross-sectional study. BMC womens health. 2015;15(7) doi: 10.1186/s12905-015-0169-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Khatoon R, Jahan N, Ahmad S, Khan HM, Rabbani T. Comparison of four diagnostic techniques for detection of Trichomonas vaginalis infection in females attending tertiary care hospital of North India. Indian journal of pathology and microbiology. 2015;58(1):36–39. doi: 10.4103/0377-4929.151172. [DOI] [PubMed] [Google Scholar]
  • 17.Ali V, Nozaki T. Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by “amitochondriate”protozoan parasites. Clinical microbiology reviews. 2007;20(1):164–187. doi: 10.1128/CMR.00019-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Forbes GL, Drayton R, Forbes GD. A case of metronidzole-resistant Trichomonas vaginalis in pregnancy. International journal of STD and AIDS. 2016;27(10):906–908. doi: 10.1177/0956462415601295. [DOI] [PubMed] [Google Scholar]
  • 19.Hawkins I, Carne C, Sonnex C, Carmichael A. Successful treatment of refractory Trichomonas vaginalis infection using intravenous metronidazole. International journal of STD and AIDS. 2015;26(9):676–678. doi: 10.1177/0956462414549201. [DOI] [PubMed] [Google Scholar]
  • 20.Meites E, Gaydos CA, Hobbs MM, Kissinger P, Nyirjesy P, Schwebke JR, Secor WE, Sobel JD, Workowski KA. A review of evidence-based care of symptomatic trichomoniasis and asymptomatic Trichomonas vaginalis infections. Clinical infectious diseases. 2015;61(8):837–848. doi: 10.1093/cid/civ738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Kauser H, Qadir M, Anwar W. Ocular side effect of tinidazole:A rare case report. Journal of family medicine and primary care. 2014;3(4):467–469. doi: 10.4103/2249-4863.148154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Gretchenl LJ. Tinidazole (Tindamax) for Trichomonas and bacterial vaginosis. American family physician. 2009;79(2):102–105. [Google Scholar]
  • 23.Thulkar J, Kriplani A, Agarwal N. A comparative study of oral single dose of metronidazole, tinidazole, secnidazole and ornidazole in bacterial vaginosis. Indian journal of pharmacology. 2012;44(2):243–245. doi: 10.4103/0253-7613.93859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.McCann JS, Horner T, Shepherd I, Quin N. 2-day treatment of trichomoniasis with nimorazole. The British journal of venereal diseases. 1974;50(5):375–376. doi: 10.1136/sti.50.5.375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Fox LM, Saravolatz LD. Saravolatz Nitazoxanide:a new thiazolide antiparasitic agent. Clinical infectious diseases. 2005;40(8):1173–1180. doi: 10.1086/428839. [DOI] [PubMed] [Google Scholar]
  • 26.Dan M, Sobel JD. Failure of nitazoxanide to cure trichomoniasis in three women. Sexually transmitted diseases. 2007;34(10):813–814. doi: 10.1097/NMD.0b013e31802f5d9a. [DOI] [PubMed] [Google Scholar]
  • 27.Lushbaugh WB, Cleary JD, Finley RW. Cytotoxicity of hamycin for Trichomonas vaginalis, HeLa and BHK-21. The journal of antimicrobial chemotherapy. 1995;36(5):795–780. doi: 10.1093/jac/36.5.795. [DOI] [PubMed] [Google Scholar]
  • 28.Tayal SC, Ochogwu SA, Bunce H. Paromomycin treatment of recalcitrant Trichomonas vaginalis. International journal of STD and AIDS. 2010;21(3):217–218. doi: 10.1258/ijsa.2009.009085. [DOI] [PubMed] [Google Scholar]
  • 29.Cudmore SL, Delgaty KL, Hayward-McClelland SF, Petrin DP, Garber GE. Treatment of infections caused by metronidazole-resistant. Trichomonas vaginalis clinical microbiology reviews. 2004;17(4):783–793. doi: 10.1128/CMR.17.4.783-793.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Löfmark S, Edlund C, Nord CE. Metronidazole is still the drug of choice for treatment of anaerobic infections. Clinical infectious diseases. 2010;50(Suppl1):S16–S23. doi: 10.1086/647939. [DOI] [PubMed] [Google Scholar]
  • 31.Land KM, Johnson PJ. Molecular basis of metronidazole resistance in pathogenic bacteria and protozoa. Drug Resistance Updates. 1999;2(5):289–294. doi: 10.1054/drup.1999.0104. [DOI] [PubMed] [Google Scholar]
  • 32.Vermani K, Garg S. Herbal medicines for sexually transmitted disease and AIDS. Journal of ethnopharmacology. 2002;80(1):49–66. doi: 10.1016/s0378-8741(02)00009-0. [DOI] [PubMed] [Google Scholar]
  • 33.Ezz Eldin HM, Badawy AF. In vitro anti-trichomonas vaginalis activity of Pistacia lentiscus mastic and Ocimum basilicum essential oil. Journal of parasitic disease. 2015;39(3):465–473. doi: 10.1007/s12639-013-0374-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.El-Sherbiny GM, ES lherbiny ET. The Effect of Commiphora molmol (Myrrh) in treatment of Trichomoniasis vaginalis infection. Iranian Red Crescent medical journal. 2011;13(7):480–486. [PMC free article] [PubMed] [Google Scholar]
  • 35.Yan Y, Gao XZ. Protein analysis of Trichomonas vaginalis treated by Pulsatilla chinensis in vitro. Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi. 2010;28(3):231–233. [PubMed] [Google Scholar]
  • 36.Ertabaklar H, Kivçak B, Mert T, Ozensoy Töz S. In vitro activity of Arbutus unedo leaf extracts against Trichomonas vaginalis trophozoites. Turkiye parazitolojii dergisi. 2009;33(4):263–265. [PubMed] [Google Scholar]
  • 37.Narcisi EM, Secor WE. In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis. Antimicrobial agents and chemotherapy. 1996;40(5):1121–1125. doi: 10.1128/aac.40.5.1121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Sherrard J, Ison C, Moody J, Wainwright E, Wilson J, Sullivan A. United Kingdom national guideline on the management of Trichomonas vaginali 2014. International journal of STD and AIDS. 2014;25(8):123–137. doi: 10.1177/0956462414525947. [DOI] [PubMed] [Google Scholar]
  • 39.Sarma GR, Kamath V. Acute painful peripheral neuropathy due to metronidazole. Neurology India. 2005;53(3):372–273. doi: 10.4103/0028-3886.16955. [DOI] [PubMed] [Google Scholar]
  • 40.Schwebke JR, Barrientes FJ. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole. Antimicrobial agents chemotherapy. 2006;50(12):4209–4210. doi: 10.1128/AAC.00814-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Semnani MK, Saeidi M, Mahdavi MR, Rahimi F. Antimicrobial effects of methanolic extracts of some species of stachys and phlomis. Journal of Mazandaran university of medical sciences. 2007;17(57):57–66. [Google Scholar]
  • 42.Forbes GL, Drayton R, Forbes GD. A case of metronidazole-resistant Trichomonas vaginalis in pregnancy. International journal of STD and AIDS. 2015;27(10):906–908. doi: 10.1177/0956462415601295. [DOI] [PubMed] [Google Scholar]
  • 43.Hashemi P, Abolghasemi MM, Fakhari AR, Ebrahimi SN, Ahmadi S. Hydrodistillation–solvent micro-extraction and GC–MS identification of volatile components of Artemisia aucheri. Chromatographia. 2007;66(3-4):283–286. [Google Scholar]
  • 44.Zomorodian K, Saharkhiz MJ, Rahimi MJ, Bandegi A, Shekarkhar G, Bandegani A, Pakshir K, Bazargani A. Chemical composition and antimicrobial activity of the essential oil of Zataria multiflora. Pharmacognosy magazine. 2006;19(2):52–59. doi: 10.4103/0973-1296.75902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Saleem M, Nazli R, Afza N, Sami A, Ali MS. Biological significance of essential oil of Zataria multiflora Boiss. Natural products research. 2004;18(6):493–497. doi: 10.1080/14786410310001608064. [DOI] [PubMed] [Google Scholar]
  • 46.Abbasgholizadeh N, Ettehad GH, Arab R, Nemati A, Barak M, Pirzadeh A, Zarei M. Antibacterial effects of Zataria multiflora Boiss. (Shiraz oregano essence) on Enterobacteriaceae species Research journal of biological sciences. 2008;3(3):345–347. [Google Scholar]
  • 47.Ettehad GH, Arab R. Evaluation of antibacterial effects of Shiraz oregano essence (Zataria multiflora Boiss) on Salmonella typhi and comparing to antibiotics. Research journal of biological sciences. 2007;2(6):674–676. [Google Scholar]
  • 48.Burt S. Essential oils:their antibacterial properties and potential applications infoods–a review. International journal of food microbiology. 2004;94(3):223–253. doi: 10.1016/j.ijfoodmicro.2004.03.022. [DOI] [PubMed] [Google Scholar]
  • 49.Chryssavgi G, Vassiliki P, Athanasios M, Kibouris T, Michael K. Essential oil compo-sition of Pistacia lentiscus L. and Myrtus communis L.:evaluation of antioxidant capacity of methanolic extracts. Food chemistry. 2008;107(3):1120–1130. [Google Scholar]
  • 50.Kalemba D, Kunicka A. Antibacterial and antifungal properties of essential oils. Current medicinal chemistry. 2003;10(10):213–229. doi: 10.2174/0929867033457719. [DOI] [PubMed] [Google Scholar]
  • 51.Ziaiye H, Azadbakht M, Abdollahi F, Shabankhani B. Effect of methanolic extracts of Artemisia aucheri Boiss Zataria multiflora Boiss. and Myrtus communis L. on Trichomonas vaginalis(in vitro) Journal of Gorgan university of medical sciences. 2006;8(1):34–38. [Google Scholar]
  • 52.Benkeblia N. Antimicrobial activity of essential oil extracts of variousonions (Allium cepa) and garlic (Allium sativum) LWT-food science and technology. 2004;37(2):263–268. [Google Scholar]
  • 53.Mikaili P, Maadirad S, Moloudizargari M, Aghajanshakeri S, Sarahroodi S. Therapeutic uses and pharmacological properties of Garlic, Shallot, and their biologically active compounds. Iranian journal of basic medical sciences. 2013;16(10):1031–1048. [PMC free article] [PubMed] [Google Scholar]
  • 54.Lee CL, Chiang LC, Cheng LH, Liaw CC, Abd El-Razek MH, Chang FR, Wu YC. Influenza A (H1N1) antiviral and cytotoxic agents from Ferula assafoetida. Journal of natural products. 2009;72(9):1568–1572. doi: 10.1021/np900158f. [DOI] [PubMed] [Google Scholar]
  • 55.Mahendra P, Bisht Sh. Ferula asafoetida:Traditional uses and pharmacological activity. Pharmacognosy reviews. 2012;6(12):141–146. doi: 10.4103/0973-7847.99948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Bahadoor Sarkari, Hadisa Tadayon, Shahrbanoo Askarian, Elahm Farnia, Mehrangiz Askarian. In vitro anti-Trichomonas activity of Freula assafoetida and garlic extract. Journal of Gorgan university of medical sciences. 2009;11(3):13–17. [Google Scholar]
  • 57.Danh LT, Han NL, Triet NDA, Zhao J, Mammucari R, Foster N. Comparison of chemical composition, antioxidant and antimicrobial activity of lavender (Lavandula angustifolia L.) essential oils extracted by supercritical CO2hexane and hydrodistillation. Food and bioprocess technology. 2012;6(12):3481–3489. [Google Scholar]
  • 58.Jianu C, Pop G, T Gruia A, Horhat FG. Chemical composition and antimicrobial activity of essential oils of lavender (Lavandula angustifolia) and lavandin (Lavandula x intermedia) grown in Western Romania. International journal of agriculture and biology. 2013;15(4):772–776. [Google Scholar]
  • 59.Ezatpur B, Badparva E, Ahmadi Sh, Rashidipur M, Ziaiye H. Investigation of anti Trichomonas vaginalis activity of Lavandula angyustifolia essential oil in invitro media. Journal of Ilam university of medical sciences. 2009;16(4):31–38. [Google Scholar]
  • 60.Huang HC, Ho YC, Lim JM, Chang TY, Ho CL, Chang TM. Investigation of the anti-melanogenic and antioxidant characteristics of Eucalyptus camaldulensis flower essential oil and determination of its chemical composition. International journal of molecular sciences. 2015;16(5):10470–10490. doi: 10.3390/ijms160510470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Hassani S, Asghari Gh, Yousefi H, Kazemian A, Rafieiean M, Yousofi Darani H. Effects of different extracts of Eucalyptus camaldulensis on Trichomonas vaginalis parasite in culture medium. Advanced biomedical research. 2013;2(47) doi: 10.4103/2277-9175.114187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Hajdari A, Novak J, Mustafa B, Franz C. Essential oil composition and antioxidant activity of Stachys sylvatica L. (Lamiaceae) from different wild populations in Kosovo. Natural product research. 2012;26(18):1676–1681. doi: 10.1080/14786419.2011.613384. [DOI] [PubMed] [Google Scholar]
  • 63.Sereshti M, Yousofi Darani H, Zebardast N, Rafean M, Manochehre Naeini K, Yousofi HA. Effect of ethanolic and watery extract of aerial parts of Stachys Lavandulifolia on Trichomonas vaginalis in vitro. Journal of medicinal plants. 2012;1(41):159–165. [Google Scholar]
  • 64.Kotan R, Cakir A, Dadasoglu F, Aydin T, Cakmakci R, Ozer H, Kordali S, Mete E, Dikbas N. Antibacterial activities of essential oils and extracts of Turkish Achillea Satureja and Thymus species against plant pathogenic bacteria. Journal of the science of food and agriculture. 2010;190(1):145–160. doi: 10.1002/jsfa.3799. [DOI] [PubMed] [Google Scholar]
  • 65.Yang H, Sung SH, Kim YC. The ethanolic extract of Juglans sinensis leaves and twigs attenuates CCl4-induced hepatic oxidative stress in rats. Pharmacognosy magazine. 2015;11(43):533–539. doi: 10.4103/0973-1296.160463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Jasna MC, Sonja MD, Gordana SC, Vesna TT. Free-radical scavenging activity of wormwood (Artemisia absinthium) extracts. Journal of the science of food and agriculture. 2004;85(2):265–272. [Google Scholar]
  • 67.Khalili B, Rafieian M, Hejazi SH, Yusefi HA, Yektaian N, Shirani-Bidabadi L. Effect of Achillea millefolium Artemisia absinthium and Juglans regia leaves extracts on Trichomonas vaginalis in vitro. Journal of Shahrekord university of medical sciences. 2011;12(4):62–69. [Google Scholar]
  • 68.Rabito MF, Britta EA, Pelegrini BL, Scariot DB, Almeida MB, Nixdorf SL, Nakamura CV, Ferreira IC. In vitro and in vivo antileishmania activity of sesquiterpene lactone-rich dichloromethane fraction obtained from Tanacetum parthenium(L.) Schultz-Bip Experimental parasitology. 2014;143:18–23. doi: 10.1016/j.exppara.2014.04.014. [DOI] [PubMed] [Google Scholar]
  • 69.Arefkhah N, Taghipur S, Yousefi M, Rafeiean M, Daneshpur S, Yousefi H. In-vitro effect of hydro-alcoholic extract of tanacetum parthenium extract on Trichomonas vaginalis. Journal of Isfahan medical school. 2013;31(236):623–629. [Google Scholar]
  • 70.Bernhoft A. Bioactive Compounds in Plants–Benefits and Risks for Man and Animals. Oslo: The Norwegian Academy of Science and Letters; 2010. [Google Scholar]
  • 71.Zarea A, Asghari GHR, Ghanadian M, Yousefi HA, Yousofi Darani H. Effect of Taxus baccata leaves fractions on Trichomonas vaginalis growth in culture medium. Armaghane danesh. 2014;18(11):888–899. [Google Scholar]
  • 72.Siddiqi HS, Mehmood MH, Rehman NU, Gilani AH. Studies on the antihypertensive and antidyslipidemic activities of Viola odorata leaves extract. Lipids in health and disease. 2012;11(6) doi: 10.1186/1476-511X-11-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Salehi L, Asghari Gh, Yousofi H, Yousofi Darani H. Effects of different extracts of Viola odorata on Trichomonas vaginalis in culture medium. Journal of Isfahan medical school. 2014;31(266):2139–2148. [Google Scholar]
  • 74.Edris AE. Pharmaceutical and therapeutic potentials of essential oils and their in dividual volatile constituents:a review. Phytotherapy research. 2007;21(4):308–323. doi: 10.1002/ptr.2072. [DOI] [PubMed] [Google Scholar]
  • 75.Fakhrie-Kashan Z, Arbabi M, Delavari M, Taghi-Zadeh M, Hooshyar H, Solaymani F. The effect of aqueous and alcoholic extracts of Pelarqonium roseum on the growth of Trichomonas vaginalis in vitro. Feyz. 2014;18(4):369–375. [Google Scholar]
  • 76.Riaz M, Zia-Ul-Haq M, Jaafar HZE, Jaafar Common mullein, pharmacological and chemical aspects. Revista brasileira de farmacognosia. 2013;23(6):948–959. [Google Scholar]
  • 77.Kashan ZF, Arbabi M, Delavari M, Hooshyar H, Taghizadeh M, Joneydy Z. Effect of Verbascum thapsus ethanol extract on induction of apoptosis in Trichomonas vaginalis in vitro. Infectious disorders-drug targets. 2015;15(2):125–130. doi: 10.2174/1871526515666150724114924. [DOI] [PubMed] [Google Scholar]
  • 78.Mantawy MM, Ali HF, Rizk MZ. Therapeutic effects of Allium sativum and Allium cepa in Schistosoma mansoni experimental infection. Revista do instituto de medicina tropical de são paulo. 2011;53(3):155–163. doi: 10.1590/s0036-46652011000300007. [DOI] [PubMed] [Google Scholar]
  • 79.Motamedi H, Darabpour E, Gholipour M, Nezhad SM. Antibacterial effect of ethanolic and methanolic extracts of Plantago ovate and Oliveria decumbens endemic in Iran against some pathogenic bacteria. International journal of pharmacology. 2010;6(2):117–122. [Google Scholar]
  • 80.Nasrabadi M, Halimi M, Nadaf M. Phytochemical screening and chemical composition of extract of Muscari neglectum. Middle-East journal of scientific research. 2013;14(4):566–569. [Google Scholar]
  • 81.Fakhrieh-Kashan Z, Arbabi M, Delavari M, Hooshyar H, Taghizadeh M. therapeutic effect of Allium cepa Oliveria decumbens Vent and Muscari neglectum against Trichomonas vaginalis In vitro. Journal of research in medical sciences. 2015;32(310):1985–1992. [Google Scholar]

Articles from Iranian Biomedical Journal are provided here courtesy of Pasteur Institute of Iran

RESOURCES